Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$13.33
+0.53%today
MKT CAP
$3.5B
+56.3% · 1Y
Full Financials
Trailing P/E14.3x
Forward P/E3.6x
EV/EBITDA-
Price/Sales-
Dividend Yield0.60%
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership-
Institutional Ownership-
Short % of Float-
Days to Cover-
1 Week+0.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| GRFS | $5.7B | 100 | 12.0 | 5.7 | 10.1 | 6.1% | 38% | 123.22 | 0.00% |
| BIIB | $28.1B | 68 | 20.6 | 11.6 | 8.7 | 7.7% | 79% | 35.18 | 0.00% |
| AMRN | $312M | 80 | - | 14.7 | - | - | - | - | 0.00% |
| GSK | $101.8B | 65 | 13.1 | 9.7 | 19.1 | 40.9% | 73% | 109.70 | 344.00% |
| SNY | $105.0B | 66 | 18.6 | 8.3 | 5.2 | 6.6% | 72% | 27.37 | 561.00% |
| BMY | $115.7B | 72 | 15.8 | 9.2 | 8.0 | 38.7% | 72% | 230.97 | 448.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for OGN.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.